pre-IPO PHARMA
COMPANIES
VC
JOBS
NEWS
CONTACT
Close ×
COMPANIES
VC
JOBS
NEWS
CONTACT
pear-therapeutics PRESS RELEASE ARCHIVE
Jun 22, 2021
Pear Therapeutics to Become a Public Company and Expand its Leadership Position in Prescription Digital Therapeutics
Jun 10, 2021
Pear Therapeutics to Participate in Cowen 6th Annual FutureHealth Conference
May 19, 2021
Pear Therapeutics Presents Results of Two Analyses Showing Decreases in Healthcare Resource Utilization and Associated Costs in Patients Using reSET-O in Treating Opioid Use Disorder
May 13, 2021
Pear Therapeutics to Participate in Citi Private Company Digital Health Conference
Apr 12, 2021
New Study, with Pear Therapeutics, to Identify Best Practices for Implementation in Primary Care of Digital Treatment for Substance Use Disorders
Apr 6, 2021
Pear Therapeutics Expands Platform with Digital Biomarkers, Machine Learning Algorithms and Sensor-Based Technologies
Apr 1, 2021
Pear Therapeutics and Prescryptive Health Announce Formulary Coverage for Prescription Digital Therapeutics reSET and reSET-O for the Treatment of Substance and Opioid Use Disorders
Mar 1, 2021
Pear Therapeutics Announces Second Closing of Series D Financing
Feb 23, 2021
Pear Therapeutics Announces Publication of Economic Analysis Showing Cost-Effectiveness of reSET-O in Treating Opioid Use Disorder
